PROOF 301: A multicenter, open-label, randomized, phase 3 trial of infigratinib
- This topic has 0 replies, 1 voice, and was last updated 2 years, 5 months ago by .
Viewing 1 post (of 1 total)
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.